Brochure | July 11, 2018

Assays To Drive Success In Anti-infective And Vaccine Development

Source: Q2 Solutions

Q2 Solutions’ scientific experts integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize your vaccine study design, ensuring high-quality data delivery and regulatory approval.

We provide state-of-the-art technologies, quality management systems, capacity and high-quality infrastructure to address the full spectrum of your anti-infective and vaccine testing needs. We offer an extensive test menu of efficacy and immunogenicity assays, standard or custom, and the strategic guidance to address your study goals to ensure better outcomes and regulatory approvals.

Download this brochure and learn how Q2 Solutions utilizes over 35 years of experience in infectious disease and immunology assay development and clinical diagnostic testing to provide you with solutions to meet your anti-infective and vaccine needs across the development continuum.